Literature DB >> 25626444

Schizophrenia spectrum and related neuropathology.

Andrea Schmitt1, Peter Falkai.   

Abstract

Entities:  

Mesh：

Year:  2015        PMID： 25626444     DOI： 10.1007/s00406-015-0579-z

Source DB:  PubMed          Journal:  Eur Arch Psychiatry Clin Neurosci        ISSN： 0940-1334            Impact factor:   5.270


× No keyword cloud information.
  9 in total

Review 1.  DSM-5 reviewed from different angles: goal attainment, rationality, use of evidence, consequences—part 2: bipolar disorders, schizophrenia spectrum disorders, anxiety disorders, obsessive-compulsive disorders, trauma- and stressor-related disorders, personality disorders, substance-related and addictive disorders, neurocognitive disorders.

Authors:  Hans-Jürgen Möller; Borwin Bandelow; Michael Bauer; Harald Hampel; Sabine C Herpertz; Michael Soyka; Utako B Barnikol; Simone Lista; Emanuel Severus; Wolfgang Maier
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2014-08-26       Impact factor: 5.270

2.  Influence of DGKH variants on amygdala volume in patients with bipolar affective disorder and schizophrenia.

Authors:  S Kittel-Schneider; T Wobrock; H Scherk; T Schneider-Axmann; S Trost; D Zilles; C Wolf; A Schmitt; B Malchow; A Hasan; M Backens; W Reith; P Falkai; O Gruber; A Reif
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2014-06-24       Impact factor: 5.270

3.  What are residual symptoms in schizophrenia spectrum disorder? Clinical description and 1-year persistence within a naturalistic trial.

Authors:  Rebecca Schennach; Michael Riedel; Michael Obermeier; Ilja Spellmann; Richard Musil; Markus Jäger; Max Schmauss; Gerd Laux; Herbert Pfeiffer; Dieter Naber; Lutz G Schmidt; Wolfgang Gaebel; Joachim Klosterkötter; Isabella Heuser; Wolfgang Maier; Matthias R Lemke; Eckart Rüther; Stefan Klingberg; Markus Gastpar; Hans-Jürgen Möller
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2014-09-27       Impact factor: 5.270

4.  Antipsychotic-induced parkinsonism is associated with working memory deficits in schizophrenia-spectrum disorders.

Authors:  Stéphane Potvin; Ginette Aubin; Emmanuel Stip
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2014-06-13       Impact factor: 5.270

5.  Evaluation of an integrated care program for schizophrenia: concept and study design.

Authors:  L Kerkemeyer; S Mostardt; J Biermann; J Wasem; A Neumann; A Walendzik; R Jahn; C Bartels; P Falkai; W Brannath; V Breunig-Lyriti; B Mester; J Timm; T Wobrock
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2014-06-07       Impact factor: 5.270

6.  Lower phosphorylated glycogen synthase kinase-3B levels in platelets of patients with schizophrenia: increment by olanzapine treatment.

Authors:  Aline Siqueira Ferreira; Nádia Rezende Barbosa Raposo; Paulo Clemente Sallet; Martinus Theodorus Van de Bilt; Rodrigo Machado-Vieira; Leda Leme Talib; Wagner Farid Gattaz
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2014-05-15       Impact factor: 5.270

7.  Structural connectivity of the salience-executive loop in schizophrenia.

Authors:  Sarina J Iwabuchi; Peter F Liddle; Lena Palaniyappan
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2014-09-26       Impact factor: 5.270

8.  Complexin2 modulates working memory-related neural activity in patients with schizophrenia.

Authors:  Johanna Hass; Esther Walton; Holger Kirsten; Jessica Turner; Rick Wolthusen; Veit Roessner; Scott R Sponheim; Daphne Holt; Randy Gollub; Vince D Calhoun; Stefan Ehrlich
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2014-10-09       Impact factor: 5.270

9.  Ribosomal DNA transcription in the dorsal raphe nucleus is increased in residual but not in paranoid schizophrenia.

Authors:  Marta Krzyżanowska; Johann Steiner; Ralf Brisch; Christian Mawrin; Stefan Busse; Katharina Braun; Zbigniew Jankowski; Hans-Gert Bernstein; Bernhard Bogerts; Tomasz Gos
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2014-08-05       Impact factor: 5.270
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.